They use laboratory parameters, including ALP, AST, age at diagnosis, TB, albumin (ALB), and platelets (PLT), to predict response to treatment (URS) or the occurrence of complications, such as liver failure, and the need for liver transplantation. This evidence concerns the gene ALB and Hepatic failure.